ArticleJGH open : an open access journal of gastroenterology and hepatology2026
Efficacy and Safety of Switching From Intravenous to Subcutaneous Vedolizumab in Japanese Patients With Ulcerative Colitis: A Study Focusing on Injection-Site Reactions.
Makoto Furuya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.